- Home
- HCKT vs AXGN Comparison
HCKT vs AXGN Comparison
Compare HCKT & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCKT
- AXGN
- Stock Information
- Founded
- HCKT 1991
- AXGN N/A
- Country
- HCKT United States
- AXGN United States
- Employees
- HCKT N/A
- AXGN N/A
- Industry
- HCKT Professional Services
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HCKT Consumer Discretionary
- AXGN Health Care
- Exchange
- HCKT Nasdaq
- AXGN Nasdaq
- Market Cap
- HCKT 594.0M
- AXGN 584.7M
- IPO Year
- HCKT 1998
- AXGN N/A
- Fundamental
- Price
- HCKT $30.32
- AXGN $12.64
- Analyst Decision
- HCKT Strong Buy
- AXGN Strong Buy
- Analyst Count
- HCKT 3
- AXGN 4
- Target Price
- HCKT $30.00
- AXGN $15.00
- AVG Volume (30 Days)
- HCKT 128.2K
- AXGN 444.1K
- Earning Date
- HCKT 11-04-2024
- AXGN 11-07-2024
- Dividend Yield
- HCKT 1.09%
- AXGN N/A
- EPS Growth
- HCKT N/A
- AXGN N/A
- EPS
- HCKT 1.22
- AXGN N/A
- Revenue
- HCKT $300,739,000.00
- AXGN $180,855,000.00
- Revenue This Year
- HCKT $8.66
- AXGN $18.91
- Revenue Next Year
- HCKT $5.16
- AXGN $12.93
- P/E Ratio
- HCKT $24.85
- AXGN N/A
- Revenue Growth
- HCKT 4.09
- AXGN 18.79
- 52 Week Low
- HCKT $20.23
- AXGN $5.55
- 52 Week High
- HCKT $32.34
- AXGN $15.90
- Technical
- Relative Strength Index (RSI)
- HCKT 65.70
- AXGN 42.96
- Support Level
- HCKT $24.06
- AXGN $12.18
- Resistance Level
- HCKT $32.34
- AXGN $14.17
- Average True Range (ATR)
- HCKT 0.92
- AXGN 1.00
- MACD
- HCKT 0.45
- AXGN -0.19
- Stochastic Oscillator
- HCKT 75.60
- AXGN 25.74
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP-based executive advisory, strategic consulting, and digital transformation firm. It provides Generative Artificial Intelligence ("Gen AI") strategy, operations, finance, human capital management, strategic sourcing, procurement, and information technology. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.